It has been commonly known that the role of BDNF-TrkB signaling in the pathogenesis and treatment mechanisms of depression (Zhang et al., 2014; Shirayama et al., 2015; Yang et al., 2015a; Fang et al., 2018). Here, NTRK2 is linked to depressive symptom measurement.